Kategorie
Antygeny nowotworowe są ważnymi markerami nowotworowymi i znajdują zastosowanie w wykrywaniu i leczeniu raka. Przeciwciała celujące w te markery mogą mieć zastosowanie diagnostyczne w wykrywaniu raka oraz określaniu jego rodzaju i stadium. Absolute Antibody oferuje szeroki wachlarz ponad 75 antygenów markerów nowotworowych, w tym anty-TAA (ang. tumor associated antigens) i anty-TSA (ang. tumor specific antigens).
| Nazwa przeciwciała [klon] | Reaktywność | Zastosowania |
| Anti-A33 [huA33] | Human | deplete, ELISA, IF, IHC |
| Anti-Alpha-fetoprotein (AFP) [AF5] | Human | WB, FC, IF |
| Anti-Alpha-ketoglutarate-dependent dioxygenase alkB homolog 3 [32C8_71] | Human | DSF, SPR, ELISA |
| Anti-BCL2 [bcl-2/100] | Human | IP, WB, IHC |
| Anti-Beta-2 microglobulin [BBM.1] | Human | Depletion, WB, IF, IHC |
| Anti-BLC2 [bcl-2/124] | Human | IP, WB, IHC |
| Anti-Breast Epithelial Mucin [BrE-3] | Human | ELISA |
| Anti-c-erbB-2 [FWP51] | Human | fusion, IP, FC, IF |
| Anti-CA125 [196-14] | Human | ELISA, IHC |
| Anti-CA125 [OC125-3.11] | Human | IP, WB, ELISA, FC, IF, IHC |
| Anti-CA125 [VK-8-1.9] | Human | IP, WB, ELISA, FC, IF, IHC |
| Anti-Canine Lymphoma [Mab231] | Dog, Human | RIA, FC |
| Anti-carcinoembryonic antigen (CEA) [Arcitumomab] | Human | IHC-P, FC, Imaging |
| Anti-carcinoembryonic antigen [A5B7] | Human | radiolabelling, therapeutic, IHC |
| Anti-CD19 [B4] | Human | FC, IF, IHC |
| Anti-CEA [BW431/26] | Human | Immunoscintigraphy |
| Anti-CEA [CH1A1A (2F1, CH1A1A-2F1)] | Human | ELISA, FC, IHC |
| Anti-CEA [EB-011] | Human | ELISA |
| Anti-CEA [EB-022] | Human | ELISA |
| Anti-CEA [T84.66] | Human | Immunoscintigraphy, immunotherapy, RIA, ELISA, FC, IHC |
| Anti-CSAp [Mu-9] | Human | therapeutic, ELISA, IHC |
| Anti-Ctip2 [25B6] | Guinea Pig, Rat, Zebrafish, Human, Cynomolgus Monkey, Mouse | CHIP, IHC-P, IP, WB, FC, IF, IHC-Fr |
| Anti-Cytokeratin 7 [OV-TL 12/30] | Human | WB, FC, IF, IHC |
| Anti-Cytokeratin 8 [TS1] | Human | IP, radioimmunotherapy, WB, ELISA, IHC |
| Anti-deltaEGFR [DH8.3] | Human | IP, WB, ELISA, FC, IHC |
| Anti-EGFR [2F8 (Zalutumumab; HuMax-EGFR)] | Human | WB, ELISA, FC |
| Anti-EGFR [2224] | Human | FC |
| Anti-EGFR [528] | Human | IHC-P, IP, NTRL, WB, FC, IF |
| Anti-EGFR [C225 (Cetuximab)] | Human | Block, FC |
| Anti-EGFR [EGFR1] | Human | IP, WB, FC, IF, IHC |
| Anti-EGFR [L2 1C] | Human | WB, ELISA, FC |
| Anti-EGFR [L3 11D] | Human | SDS-PAGE, WB, ELISA, FC |
| Anti-EGFR [Matuzumab] | Human | antagonist, WB, Block, ELISA, FC, IF |
| Anti-EGFR [S3 12D] | Human | ICC, WB, ELISA, IF, IHC |
| Anti-EGFR [S4 10H] | Human | WB, ELISA, FC |
| Anti-EGFR domain III [h-R3 (Nimotuzumab)] | Human | Block, FC, IHC |
| Anti-EGFRvIII [L8A4] | Human | Biacore, WB, ELISA, FC, IF, IHC |
| Anti-Endosialin [scFv78] | Human, Mouse | tumor imaging, ELISA, FC |
| Anti-EPCAM [B38.1] | Human | RIA, ELISA |
| Anti-erbB-2 (Her-2/neu) [4D5-8 (trastuzumab)] | Human | ELISA, FC, IHC |
| Anti-ERBB2 [SAIC-02A-7] | Human | immunoMRM, WB, ELISA |
| Anti-GA733-2 [FU-MK-1] | n/a | IB, ICC, WB, ELISA, IHC |
| Anti-HER2 [4D5] | Human | crystallization, in vivo, inibition, IP, therapeutic, FC |
| Anti-HER2 [C7b] | Human | cytometric bead array, WB, ELISA, FC, IHC |
| Anti-HER2 [ML3-9 (C6ML3-9)] | Human | RIA, SPR, FC |
| Anti-HER2/neu [SER4] | Human | ELISA |
| Anti-HER3 [A5 ] | Human | SPR, FC |
| Anti-HER4 [B6 (HER4.B6)] | Human | ELISA |
| Anti-high MWT epithelial antigens [KC4G3] | Human | WB, IHC |
| Anti-Human Ephrin Type A receptor 2 [1C1] | Human | agonist, internalizing, WB, ELISA, FC, IF |
| Anti-Ki-67 [685P3B2 ] | Human | WB, ELISA, IHC |
| Anti-Ki-67 [73043-24E8] | Human | WB, ELISA, IHC |
| Anti-Lewis Y [3S193] | Human | humanisation, ELISA, IHC |
| Anti-LeY [BR96] | Human | ELISA, IHC |
| Anti-LeY [H18A] | Human | ELISA, IHC |
| Anti-LMP1 [H3] | Epstein-Barr virus (EBV) | inhibit, IP, ELISA, IF |
| Anti-m5C [FMC-9] | Species independent | ICC, IPP, WB, ELISA, IHC |
| Anti-MAGE-3 [21B4] | Human | IP, WB, ELISA, IHC |
| Anti-Mesothelin [11-25] | Human | IP, ELISA, FC |
| Anti-Mesothelin [C10] | Human | SPR, ELISA, IHC |
| Anti-Mesothelin [IC14-30] | Human | ELISA |
| Anti-Mesothelin [K1] | Cynomologous monkey, Human | RIA, SPR, WB, ELISA, IF, IHC |
| Anti-MPF [20-10] | Human | IP, WB, ELISA |
| Anti-MPF [41-28] | Human | IP, WB, ELISA |
| Anti-MUC-1 [E29] | Human | WB, IHC |
| Anti-MUC1 [HMFG1 (1.10.F3)] | Human | IP, RIA, WB, ELISA, IF, IHC |
| Anti-MUC1 [HMFG2] | Human | ELISA, IHC, Imaging |
| Anti-MUC1 [Mc5] | Human | IP, IRA, WB, ELISA, IHC |
| Anti-MUC1 [PAM4] | Human | therapeutic, WB, ELISA, FC, IHC |
| Anti-MUC1 [SM3] | Human | ELISA; IHC-P, FC, IHC-Fr |
| Anti-NSE [E1-7E2] | Human | WB, ELISA |
| Anti-NSE [E2-4F6] | Human | WB, ELISA |
| Anti-OA3 [OV-TL3] | Human | IB, WB, Block, ELISA, IF, IHC |
| Anti-osteosarcoma-associated cell membrane antigen [TP-1] | Dog, Human | radioimmunodetection, IF, IHC |
| Anti-osteosarcoma-associated cell membrane antigen [TP-3] | Dog, Human | radioimmunodetection, IF, IHC |
| Anti-p21 [Y13-238] | Human, Mouse | IP; |
| Anti-p53 [PAb421] | Monkey, Rabbit, Rat, Human, Mouse | IHC -P, in vivo, IP, WB, ELISA, IF, IHC-Fr |
| Anti-polymorphic epithelial mucin [CTM01] | Human | IP, therapeutic, IHC |
| Anti-PSA [8G8F5] | Human | ELISA |
| Anti-PSA [scFv B8] | Human | SPR, WB |
| Anti-PSMA [11d1e5E10] | Human | ELISA, IHC |
| Anti-PSMA [J591] | Human | IP, therapeutic, WB, ELISA, FC, IF, IHC |
| Anti-S100 [S1-61] | Human | WB, IHC |
| Anti-S100B [1C8] | Human | therapeutic, ELISA |
| Anti-Synaptophysin [SP15] | Cat, Hamster, Pig, Rat, Human | WB, ELISA, IHC |
| Anti-TAG-72 [Minretumomab (CC49 )] | Human | RIA, therapeutic, WB, FC, IHC |
| Anti-Tenascin [I-81C6 (Neuradiab)] | Human | cross-competition assay, immunoreactivity, radioiodination, ELISA |
| Anti-Tn Antigen [237mAb] | Human, Mouse | WB, ELISA |
| Anti-trastuzumab (anti-idiotype) [scFv40] | Human | immunogen, Block |
| Anti-trastuzumab (anti-idiotype) [scFv69] | Human | immunogen, Block |
| Anti-TRP-1, gp75 [TA99] | Human | IP, WB, ELISA, FC, IF, IHC-Fr |
| Anti-Tumor associated glycoprotein (TAG) 72 [B72.3 (Satumomab)] | Human | FC, IHC, Imaging |
| Anti-VAP-1 [2D10] | Human | IP, WB, ELISA, FC, IHC |
| Anti-VAP-1 [3F10] | Human | ELISA, IHC |
| Anti-VAP-1 [3G6] | Human | ELISA, IHC |
| Anti-VAP-1 [TK8-14] | Human | IP, WB, ELISA, FC, IHC |
Aktualne promocje
ZAPRASZAMY DO ZAPOZNANIA SIĘ Z PRZECIWCIAŁAMI CYTOMETRYCZNYMI FIRMY ELABSCIENCE.
SZEROKI WYBÓR FLUOROCHROMÓW POZWALA NA DOKŁADNE DOPASOWANIE PRZECIWCIAŁ DO SPECYFIKI BADAŃ
OBECNIE WSZYSTKIE PRODUKTY TEJ KATEGORII DOSTĘPNE SĄ Z RABATEM 10%
